Sarepta Therapeutics (SRPT) Soars 30.1%: Is Further Upside Left in the Stock?

Sarepta Therapeutics (SRPT) shares ended the last trading session 30.1% higher at $160.72. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 2.9% loss over the past four weeks. The label expansion is mainly supported by data from the phase III EMBARK study, announced last October. Though the study failed to achieve its primary endpoint, it achieved statistical significance on all pre-specified key secondary endpoints ...